On Tuesday, Nuvation Bio Inc (NYSE: NUVB) was -6.58% drop from the session before settling in for the closing price of $5.17. A 52-week range for NUVB has been $1.54 – $5.55.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -49.14%. When this article was written, the company’s average yearly earnings per share was at 71.86%. With a float of $231.51 million, this company’s outstanding shares have now reached $341.76 million.
Nuvation Bio Inc (NUVB) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Nuvation Bio Inc stocks. The insider ownership of Nuvation Bio Inc is 32.56%, while institutional ownership is 53.67%. The most recent insider transaction that took place on Oct 27 ’25, was worth 502,460. In this transaction CHIEF SCIENTIFIC OFFICER of this company sold 100,000 shares at a rate of $5.02, taking the stock ownership to the 0 shares. Before that another transaction happened on Oct 27 ’25, when Company’s Officer proposed sale 100,000 for $4.85, making the entire transaction worth $485,000.
Nuvation Bio Inc (NUVB) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.12 earnings per share (EPS) during the time that was better than consensus figure (set at -0.12) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 71.86% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 44.79% during the next five years compared to -49.14% drop over the previous five years of trading.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
You can see what Nuvation Bio Inc (NUVB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 8.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 61.98.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach -0.46 in one year’s time.
Technical Analysis of Nuvation Bio Inc (NUVB)
Compared to the last year’s volume of 5.15 million, its volume of 12.98 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 71.67%.
During the past 100 days, Nuvation Bio Inc’s (NUVB) raw stochastic average was set at 81.91%, which indicates a significant increase from 67.12% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.41 in the past 14 days, which was higher than the 0.23 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.72, while its 200-day Moving Average is $2.57. Nevertheless, the first resistance level for the watch stands at $5.37 in the near term. At $5.92, the stock is likely to face the second major resistance level. The third major resistance level sits at $6.64. If the price goes on to break the first support level at $4.10, it is likely to go to the next support level at $3.38. Now, if the price goes above the second support level, the third support stands at $2.83.
Nuvation Bio Inc (NYSE: NUVB) Key Stats
There are 342,273K outstanding shares of the company, which has a market capitalization of 1.66 billion. As of now, sales total 7,870 K while income totals -567,940 K. Its latest quarter income was 4,830 K while its last quarter net income were -59,010 K.
